Compare GDL & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GDL | OKYO |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.2M | 81.3M |
| IPO Year | N/A | 2021 |
| Metric | GDL | OKYO |
|---|---|---|
| Price | $8.43 | $1.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 6.7K | ★ 141.1K |
| Earning Date | 01-01-0001 | 07-18-2025 |
| Dividend Yield | ★ 6.02% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.24 | $1.34 |
| 52 Week High | $8.67 | $3.20 |
| Indicator | GDL | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 51.07 | 46.00 |
| Support Level | $8.41 | $1.45 |
| Resistance Level | $8.53 | $1.73 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 66.67 | 44.87 |
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.